Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: back to .21 does not bode well for confidence

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Re: back to .21 does not bode well for confidence

paylslyone

Jun 24, 2008 06:02AM

Re: back to .21 does not bode well for confidence

emtnester

Jun 24, 2008 06:05AM

Re: back to .21 does not bode well for confidence - Emt

SGE1

Jun 24, 2008 06:52AM

Re: back to .21 does not bode well for confidence - Emt

emtnester

Jun 24, 2008 07:06AM

Re: back to .21 does not bode well for confidence - Emt

SGE1

Jun 24, 2008 07:44AM

emtnester

Rank: President [?]

Points: 4671 [?]

Votes: 75 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: back to .21 does not bode well for confidence - SGE

in response to

Re: back to .21 does not bode well for confidence - Emt

SGE1

posted on Jun 24, 2008 07:48AM

You said: Further, it is my understanding that the useful benefit of using one cannot be fully realized without incorporating the other.

I agree 100%...thus...having the 148 complete does us little good if the 336 is still in limbo. Their integration and closeness is such that both are needed to a good licensing program to succeed...IMO

2 Recommendations

Re: back to .21 does not bode well for confidence - SGE

PxPEnPassant

Jun 24, 2008 07:53AM

Re: back to .21 does not bode well for confidence - SGE - Emt

SGE1

Jun 24, 2008 08:08AM

Re: back to .21 does not bode well for confidence - SGE

optymystic

Jun 24, 2008 08:10AM

Re: back to .21 does not bode well for confidence - SGE - Emt - SGE

fatwollit